- Home
- AEMD vs NDRA Comparison
AEMD vs NDRA Comparison
Compare AEMD & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEMD
- NDRA
- Stock Information
- Founded
- AEMD 1984
- NDRA 2007
- Country
- AEMD United States
- NDRA United States
- Employees
- AEMD N/A
- NDRA N/A
- Industry
- AEMD Medical/Dental Instruments
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AEMD Health Care
- NDRA Health Care
- Exchange
- AEMD Nasdaq
- NDRA Nasdaq
- Market Cap
- AEMD 4.1M
- NDRA 3.9M
- IPO Year
- AEMD N/A
- NDRA 2017
- Fundamental
- Price
- AEMD $0.75
- NDRA $6.26
- Analyst Decision
- AEMD Buy
- NDRA Strong Buy
- Analyst Count
- AEMD 2
- NDRA 1
- Target Price
- AEMD $28.75
- NDRA $38.00
- AVG Volume (30 Days)
- AEMD 625.5K
- NDRA 37.4K
- Earning Date
- AEMD 11-12-2025
- NDRA 11-14-2025
- Dividend Yield
- AEMD N/A
- NDRA N/A
- EPS Growth
- AEMD N/A
- NDRA N/A
- EPS
- AEMD N/A
- NDRA N/A
- Revenue
- AEMD N/A
- NDRA N/A
- Revenue This Year
- AEMD N/A
- NDRA N/A
- Revenue Next Year
- AEMD N/A
- NDRA N/A
- P/E Ratio
- AEMD N/A
- NDRA N/A
- Revenue Growth
- AEMD N/A
- NDRA N/A
- 52 Week Low
- AEMD $0.60
- NDRA $2.90
- 52 Week High
- AEMD $8.44
- NDRA $22.68
- Technical
- Relative Strength Index (RSI)
- AEMD 43.10
- NDRA 77.50
- Support Level
- AEMD $0.71
- NDRA $5.30
- Resistance Level
- AEMD $0.83
- NDRA $6.09
- Average True Range (ATR)
- AEMD 0.05
- NDRA 0.39
- MACD
- AEMD 0.03
- NDRA 0.14
- Stochastic Oscillator
- AEMD 52.83
- NDRA 95.83
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.